Perrigo (PRGO) EPS (Basic) Growth (1y) (2013 - 2026)
Perrigo (PRGO) EPS (Basic) Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -301.82% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 1.21% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -17.09% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 13.91% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -2,504.14% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 31.67% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 388.06% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Perrigo | 1.91 Bn | 1.51 Bn | 313.90 Mn | 979.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | -77.33% |
| Mar 28, 2026 | -32.88% |
| Dec 31, 2025 | -15.74% |
| Sep 27, 2025 | -51.84% |
| Jun 28, 2025 | -190.26% |
| Mar 29, 2025 | -207.05% |
| Dec 31, 2024 | 35.78% |
| Sep 28, 2024 | -179.21% |
| Jun 29, 2024 | -432.91% |
| Mar 30, 2024 | -9.15% |
| Dec 31, 2023 | 58.43% |
| Sep 30, 2023 | -144.15% |
| Jul 1, 2023 | -148.71% |
| Apr 1, 2023 | -71.57% |
| Dec 31, 2022 | 51.44% |
| Oct 1, 2022 | 153.68% |
| Jul 2, 2022 | -100.37% |
| Apr 2, 2022 | -103.10% |
| Dec 31, 2021 | 81.33% |
| Oct 2, 2021 | 97.18% |